Neuberger Berman High Yield Strategies Fund Inc. (NYSEAMERICAN:NHS - Get Free Report) declared a dividend on Thursday, October 31st, NASDAQ reports. Investors of record on Friday, November 15th will be paid a dividend of 0.0905 per share by the investment management company on Friday, November 29th. The ex-dividend date is Friday, November 15th.
Neuberger Berman High Yield Strategies Fund stock traded down $0.16 during mid-day trading on Friday, reaching $8.04. 189,014 shares of the company traded hands, compared to its average volume of 111,709. Neuberger Berman High Yield Strategies Fund has a fifty-two week low of $7.23 and a fifty-two week high of $8.67.
Neuberger Berman High Yield Strategies Fund Inc is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Neuberger Berman High Yield Strategies Fund, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neuberger Berman High Yield Strategies Fund wasn't on the list.
While Neuberger Berman High Yield Strategies Fund currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.